Registration

MILLER STRATEGIES, LLC for ALZHEON, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues related to FDA drug approval process and therapies for Alzheimer's disease.

LobbyistCovered position, as disclosed
ASHLEY GUNN New Special Asst to the President, Senior Director, White House Office of Cabinet Affairs.
JEFFREY MILLER New —
JAMES MIN New Chief of Staff, Rep. Vince Fong; Chief of Staff, Office of the 20th District of California; Chief of Staff, Deputy Chief of Staff, and Counsel, Speaker Kevin McCarthy; Chief of Staff, Rep. Bill Thomas.

Health Issues HCR

Issues related to FDA drug approval process and therapies for Alzheimer's disease.

LobbyistCovered position, as disclosed
ASHLEY GUNN New Special Asst to the President, Senior Director, White House Office of Cabinet Affairs.
JEFFREY MILLER New —
JAMES MIN New Chief of Staff, Rep. Vince Fong; Chief of Staff, Office of the 20th District of California; Chief of Staff, Deputy Chief of Staff, and Counsel, Speaker Kevin McCarthy; Chief of Staff, Rep. Bill Thomas.

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.